SETDB1 and cancer: Given that SETDB1 has been implicated in several diseases, including cancers, neuropsychiatric disorders, congenital cardiovascular diseases and inflammatory bowel disease (IBD), SETDB1 has attracted considerable attention for its potential as a therapeutic target50.